Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT03983824 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03983824
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2027-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.